Loading the company…
Loading the company…
In the last ten years FDA made 45 decisions for Saluda Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2024 (14). The latest was on 2026-10-16.
| Family | Decisions on record |
|---|---|
| Spinal cord & DRG stimulation | 45 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-10-16 | PMA | P190002-S052 | Saluda Medical Evoke SCS System · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-10-15 | PMA | P190002-S051 | Saluda Medical Evoke SCS System · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-06-29 | PMA | P190002-S038 | Saluda Medical Evoke SCS System; Closed Loop Stimulator (CLS) (REF: 3042) · Change Design/Components/Specifications/Material |
| 2026-06-29 | PMA | P190002-S039 |
In 2025, Saluda Medical reported engagement with 3,996 surgeons and other clinicians in the states MedaRep covers, worth $2.3M in consulting, speaking, meals and travel for its device products, the most in California ($382K to 343). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: California ($382K, 343 engaged), Arkansas ($231K, 30 engaged), Florida ($222K, 542 engaged), Arizona ($172K, 141 engaged), North Carolina ($144K, 169 engaged).
| CAP24 Paddle Lead, Passing Elevator, Evoke CLS (REF 3042), Clarity Programming Application (CPA), and RECAP Viewer · Labeling Change - Indications/instructions/shelf life/tradename |
| 2026-06-12 | PMA | P190002-S049 | Saluda Medical Evoke SCS System · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Saluda Medical.